{"doi":"10.1016/j.bmcl.2011.01.001","title":"Scaffold oriented synthesis. Part 4: Design, synthesis and biological evaluation of novel 5-substituted indazoles as potent and selective kinase inhibitors employing heterocycle forming and multicomponent reactions","abstract":null,"journal":"Bioorganic &amp; Medicinal Chemistry Letters","year":2011,"id":675561,"datarank":2.35932733117179,"base_score":3.713572066704308,"endowment":3.713572066704308,"self_citation_contribution":0.5570358100056463,"citation_network_contribution":1.8022915211661434,"self_endowment_contribution":0.5570358100056463,"citer_contribution":1.8022915211661434,"corpus_percentile":null,"corpus_rank":null,"citation_count":40,"citer_count":40,"citers_with_citation_signal":38,"citers_with_endowment":38,"datacite_reuse_total":0,"is_dataset":false,"is_dataset_confidence":null,"is_data_producer":false,"deposit_databanks":null,"is_oa":false,"file_count":0,"downloads":0,"has_version_chain":false,"published_date":null,"fair_score":null,"fair_percentile":null,"algorithm_id":"datarank_citation_only_1hop_v6","ranking_scope":"data_only","authors":[{"id":1765111,"name":"Brian D. Wakefield","orcid":null,"position":1,"is_corresponding":false},{"id":1765112,"name":"Alan Gasiecki","orcid":null,"position":2,"is_corresponding":false},{"id":1765113,"name":"Douglas Kalvin","orcid":null,"position":3,"is_corresponding":false},{"id":1394144,"name":"Eric F. Johnson","orcid":"0000-0002-2909-865X","position":4,"is_corresponding":false},{"id":1765114,"name":"Peter Kovar","orcid":null,"position":5,"is_corresponding":false},{"id":1765115,"name":"Stevan W. Djuric","orcid":null,"position":6,"is_corresponding":false},{"id":1765110,"name":"Irini Akritopoulou-Zanze","orcid":null,"position":0,"is_corresponding":false}],"reference_count":0,"raw_metadata":{"has_enrichment":true,"resolved":true,"title":"Scaffold oriented synthesis. Part 4: Design, synthesis and biological evaluation of novel 5-substituted indazoles as potent and selective kinase inhibitors employing heterocycle forming and multicomponent reactions","abstract":"We report the synthesis and biological evaluation of 5-substituted indazoles as kinase inhibitors. The compounds were synthesized in a parallel synthesis fashion from readily available starting materials employing heterocycle forming and multicomponent reactions and were evaluated against a panel of kinase assays. Potent inhibitors were identified for Gsk3β, Rock2, and Egfr.","is_dataset_classified":null,"base_score":3.713572066704308,"endowment":3.713572066704308,"datacite_reuse_total":0,"file_count":0,"downloads":0,"views":0,"has_version_chain":false,"is_dataset":false,"is_oa":false,"pmid":"21288717","pmcid":null,"openalex_id":"https://openalex.org/W1979076228","authors":[],"funders":[],"total_grants":0,"fwci":1.1798,"citation_percentile":0.76328138,"influential_citations":0,"citation_trend":[{"year":2012,"count":3},{"year":2014,"count":4},{"year":2015,"count":4},{"year":2016,"count":4},{"year":2017,"count":2},{"year":2018,"count":3},{"year":2019,"count":4},{"year":2020,"count":2},{"year":2021,"count":3},{"year":2022,"count":2},{"year":2023,"count":3},{"year":2024,"count":3},{"year":2025,"count":2}],"oa_status":"green","license":"https://www.elsevier.com/legal/tdmrep-license","oa_locations":[{"url":"https://doi.org/10.7270/q2c24wqd","host_type":"repository"},{"url":"https://doi.org/10.7270/q2c24wqd","host_type":"repository"},{"url":"https://api.elsevier.com/content/article/PII:S0960894X11000114?httpAccept=text/xml","host_type":"publisher"},{"url":"https://api.elsevier.com/content/article/PII:S0960894X11000114?httpAccept=text/plain","host_type":"publisher"},{"url":"https://doi.org/10.1016/j.bmcl.2011.01.001","host_type":"journal"},{"url":"https://pubmed.ncbi.nlm.nih.gov/21288717","host_type":"repository"}],"fields_of_study":["Synthesis and biological activity","Quinazolinone synthesis and applications","Click Chemistry and Applications","Drug Design","Heterocyclic Compounds","Indazoles","Molecular Structure","Protein Kinase Inhibitors","Structure-Activity Relationship"],"mesh_terms":["Heterocyclic Compounds","Indazoles","Structure-Activity Relationship","Drug Design","Molecular Structure","Protein Kinase Inhibitors"],"keywords":["Chemistry","ROCK2","Chemical synthesis","Kinase","Scaffold","Combinatorial chemistry","Enzyme inhibitor","Bioisostere","Structure–activity relationship","Enzyme","In vitro","Biochemistry","Rho-associated protein kinase"],"sdg_mappings":[],"linked_datasets":[],"clinical_trials":[],"software_tools":[],"database_accessions":[],"source":"live","citation_network_status":"fetched"},"created_at":"2026-08-17T01:21:16.913432Z","pmid":null,"pmcid":null,"fwci":null,"citation_percentile":null,"influential_citations":0,"oa_status":null,"license":null,"views":0,"total_file_size_bytes":0,"version_count":0,"fair_f":null,"fair_a":null,"fair_i":null,"fair_r":null,"fair_zscore":null,"fair_rationale":null,"fair_model":null,"fair_agent_version":null,"fair_fulltext_source":null,"fair_has_llm":null,"fair_computed_at":null,"clinical_trials":[],"software_tools":[],"db_accessions":[],"linked_datasets":[],"topics":[]}